Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2024-05-24 M&A Activity
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Aktulizacja celów dla projektu BACTEROMIC
M&A Activity Classification · 95% confidence The document is a detailed update from Scope Fluidics S.A. regarding the strategic goals for its BACTEROMIC project, specifically focusing on commercialization, product portfolio expansion (new panels like UNIMAX and Positive Blood Culture), and necessary certifications (IVDR). It discusses adapting plans based on M&A market sentiment and outlines specific technical and regulatory milestones for 2024-2025. This content—a comprehensive update on strategy, product development, and operational goals, often issued outside of standard quarterly/annual reporting cycles—is characteristic of an Investor Presentation (IP) or a detailed Management Discussion and Analysis (MDA) section, but given the focus on future strategy, product roadmap, and market positioning aimed at potential strategic transactions (M&A), it aligns best with an Investor Presentation (IP) which often contains this level of forward-looking detail. It is not a standard regulatory filing (10-K, IR, ER, MRQ). It is too detailed and strategic to be a simple Report Publication Announcement (RPA). Since it details strategy, product development, and market outlook for investors, Investor Presentation (IP) is the most fitting category.
2024-05-24 Polish
Aktualizacja celów dla projektu BACTEROMIC - Content (PL)
Board/Management Information Classification · 99% confidence The document is a formal announcement from Scope Fluidics S.A. regarding the approval by the Supervisory Board of updated operational goals for the BACTEROMIC project, referencing previous strategy and transaction reports. It details strategic objectives (commercial launch, product portfolio expansion) and concludes by stating that the description of the updated goals is an attachment to the report ("Opis zaktualizowanych celów stanowi załącznik do niniejszego raportu."). Since the document itself is an announcement about updated strategic/operational goals and refers to an attachment containing the details, it fits best as a general Regulatory Filing (RNS) or potentially a Management Report (MDA) if the content were more explanatory. However, given the nature of updating operational targets related to a strategic transaction, and the fact that it is a formal, brief announcement referencing an attachment, RNS is the most appropriate general regulatory category for non-standard, material updates that don't fit 10-K, ER, or IR. It is not a full report, an earnings release, or a specific financing/dividend notice. It is a material, regulatory-style update.
2024-05-24 Polish
Opinia biegłego rewidenta dot. jednostkowego SF Scope Fluidics
Regulatory Filings Classification · 95% confidence The provided document text consists almost entirely of XML structures related to digital signatures (Signature, SignedInfo, DigestValue, X509Certificate, etc.). This structure is characteristic of digitally signed regulatory filings or documents submitted electronically to regulatory bodies, often in formats like XML or XBRL. Crucially, the document does not contain typical narrative content found in Annual Reports (10-K), Earnings Releases (ER), or Interim Reports (IR). It lacks financial tables, management discussion, or specific section headers related to business operations or financial performance. However, the presence of a digital signature block, especially one referencing specific file names like "Scope_JSF_SBR_2023-12-31_pl.xhtml" and containing certificate information (including Polish identifiers like 'PL', 'VATPL-5170359458', and 'Narodowy Bank Polski'), strongly suggests this is a component of a formal regulatory submission. Since the content is purely metadata/security structure and not the report itself, and it is clearly a formal submission component, the most appropriate general classification is 'Regulatory Filings' (RNS), which serves as the fallback for formal, non-narrative regulatory components that don't fit specific categories like DIRS or DIV. Given the highly technical and non-content nature, it is not an Investor Presentation (IP), Fund Factsheet (FS), or a Call Transcript (CT). It is a signed artifact of a filing.
2024-04-19 Polish
Opinia biegłego rewidenta dot. jednostkowego SF Scope Fluidics
Audit Report / Information Classification · 95% confidence The document text provided is extremely long (3,928,404 characters) and appears to be the raw HTML/CSS structure generated by a PDF conversion tool (pdf2htmlEX), indicated by the extensive CSS styling, font definitions (WOFF data), and the title 'Scope_JSF_SBR_2023-12-31_pl.xhtml'. This structure strongly suggests the document is a full, converted report, not a brief announcement about a report. Given the length and the nature of corporate filings, this is most likely a comprehensive annual or interim report. Since the title contains a date ('2023-12-31'), it represents a full period filing. Without explicit '10-K' headers, the most appropriate classification for a comprehensive, period-specific report is the Interim/Quarterly Report (IR) or Annual Report (10-K). Since the length is massive and it's a full conversion, it leans towards a comprehensive report. However, the presence of 'SBR' (likely related to regulatory reporting or supervision) and the Polish language context ('pl.xhtml') suggests a regulatory filing that is comprehensive. Given the options, and the fact that it is a full document conversion rather than a short announcement, I will classify it as an Interim/Quarterly Report (IR) as it is the most general comprehensive report category besides 10-K, which usually has specific SEC headers not visible here. If this were a US filing, 10-K would be likely, but for a general comprehensive report, IR is safer than assuming 10-K without confirmation. However, the sheer size (nearly 4MB of text content) strongly implies a full statutory report. I will default to the comprehensive report category that covers non-annual periods, IR, as 10-K is specifically for the *Annual* report. FY 2023
2024-04-19 Polish
Opinia biegłego rewidenta dot. skonsolidowanego SF GK Scope Fluidics
Regulatory Filings Classification · 95% confidence The provided document text consists almost entirely of XML structures related to digital signatures (Signature, SignedInfo, KeyInfo, X509Data, etc.). This structure is characteristic of an electronically signed document, often used for official regulatory filings or attachments. Crucially, the text contains a reference to a file named "Scope_SSF_SBR_2023-12-31_pl.xhtml" and a signing time of '2024-04-16T17:08:42Z'. The presence of a specific file reference within a signature block, especially one referencing a date (2023-12-31), suggests this is metadata or a wrapper around a primary financial document. Since the content itself is not the financial report (like 10-K or IR) but rather the digital signature wrapper, and given the document length is substantial (10578 chars), it is highly likely this is the regulatory filing wrapper itself, or the document is too technical/non-standard to fit a primary report type. However, the structure strongly suggests a formal submission where the content is signed. If this were an announcement *about* a report, it would be RPA or RNS. Since the content is the signature block for a specific file (an XHTML document), and without further context on the nature of the signed file, the most appropriate general category for a complex, signed regulatory artifact that isn't a standard report form is the fallback category. Given the highly technical, non-narrative content (pure XML signature data), it does not fit ER, IR, 10-K, IP, or CT. It is not a management change (MANG) or dividend notice (DIV). It is a formal, signed submission, making RNS (Regulatory Filings - general/fallback) the best fit for this technical artifact.
2024-04-19 Polish
Opinia biegłego rewidenta dot. skonsolidowanego SF GK Scope Fluidics
Audit Report / Information Classification · 95% confidence The document text provided is extremely long (over 4 million characters) and appears to be the raw HTML/CSS structure generated from converting a PDF document, as indicated by the presence of extensive CSS styling, font definitions (like 'Consolia XBRL Tools v2.11.6.0'), and page layout tags ('pf', 'pc'). The title tag mentions 'Scope_SSF_SBR_2023-12-31_pl.xhtml'. This strongly suggests the document is a comprehensive financial report or filing that has been converted to HTML/XML format, likely containing detailed financial statements or regulatory disclosures for the period ending December 31, 2023. Given the length and the nature of the content (implied by the XBRL tools reference and the date), it is most likely a full Annual Report (10-K) or a comprehensive Interim/Quarterly Report (IR). Since the document is massive and appears to be the full content rather than a short announcement, I will classify it as the most comprehensive annual filing, the 10-K, unless specific quarterly indicators are present. The presence of 'XBRL Tools' often correlates with major SEC filings like 10-K or 10-Q. Without explicit '10-K' headers, but given the size and structure suggesting a full annual filing converted from a source document, 10-K is the best fit among the comprehensive reports. If it were a short announcement about a report, RPA would be chosen, but this is the report content itself, albeit in a raw format. FY 2023
2024-04-19 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.